Trial Profile
CPT-11 or weekly PTX and Trastuzumab for previously treated HER2 positive advanced gastric cancer -Phase II study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel; Trastuzumab
- Indications Gastric cancer
- Focus Therapeutic Use
- 06 Jan 2013 Additional lead trial centre added as reported by University Hospital Medical Information Network - Japan record.
- 30 Dec 2011 New trial record